★ Healing

AHK-Cu

Healing · 100mg × 10 vials

AHK-Cu tells dormant hair follicles to wake up, extends how long each follicle stays in active growth, and pulls in new blood supply around the follicle so the new hair grows in thicker.

✓ 98%+ Purity ✓ Lab Tested ✓ COA on Request ✓ Discreet Shipping ✓ Direct Support
📋 Certificate of Analysis Request the third-party COA via Telegram
Quick Start
🧪
Format
Injectable (reconstituted) · 100mg × 10 vials
🎯
Who it's for
hair thinning
💉
How it's run
1 mg SubQ daily, OR 0.05-0.1% topical scalp serum nightly
When you'll notice
8-12 weeks
Pricing
$115from · kit of 10
US: 2-5 day · Intl: 7-14 day
+ $40 ship · singles $20 · free over $1k per tier
100mg × 10 vials$115
Order / Consult on Telegram →
~25-60 min plasma (tissue effects persist days)
Half-life
continuous
Cycling
8-12 weeks
First effects
healing
Class
Overview

What Is AHK-Cu?

AHK-Cu is a synthetic copper-binding tripeptide (alanyl-L-histidyl-L-lysine) chelated to a copper(II) ion. It is a structural cousin of GHK-Cu where the glycine residue at position 1 is replaced by alanine, and that single amino-acid swap shifts its tissue preference from broad dermal regeneration toward hair-follicle-specific activity. Mechanistically AHK-Cu acts on the dermal papilla, the mesenchymal cell cluster at the base of the hair follicle that controls the anagen (growth) phase of the hair cycle. Pickart and Uno's foundational work (and later in vitro studies from Procyte and Loren Pickart's lab) showed AHK-Cu directly increases dermal papilla cell proliferation, prolongs the anagen phase, and induces VEGF expression in follicular cells, which drives perifollicular angiogenesis (new capillaries around the follicle) so the regrowing hair gets better blood supply, oxygen, and nutrient delivery. It also upregulates basic fibroblast growth factor (bFGF/FGF-2) and keratinocyte growth factor (KGF), both of which push the follicle from telogen (resting) into anagen (active growth). The copper ion serves the same cofactor role as in GHK-Cu: it loads into lysyl oxidase (collagen crosslinking around the follicle and scalp dermis) and superoxide dismutase (antioxidant defense for the perifollicular environment, which matters because oxidative stress is a documented driver of androgenetic alopecia). Where GHK-Cu is the generalist copper peptide that hits skin, scalp, wound, and follicle, AHK-Cu is the specialist that concentrates its activity on the follicle and the dermal papilla. Plasma half-life is similar to GHK-Cu (25-60 minutes systemically) but tissue-bound effects on follicle cycling persist over a full hair cycle of 8-12 weeks, which is why visible regrowth lags injection or topical application by months, not days. In plain language: AHK-Cu tells dormant hair follicles to wake up, extends how long each follicle stays in active growth, and pulls in new blood supply around the follicle so the new hair grows in thicker.

Protocols

Typical dose ranges by experience level - educational reference. Message us and we tailor it to you.

Protocol1 mg SubQ daily, OR 0.05-0.1% topical scalp serum nightly
FrequencyDaily
Duration8-12 weeks minimum before assessing regrowth (one full anagen cycle); 4-6 month commitment realistic for visible density change

First-timer default is the 100 mg vial (50 days research at 2 mg/day). Most beginners pair topical AHK-Cu with topical GHK-Cu (the two copper peptides cover hair-follicle plus scalp/skin together, the most common compounded combo in community formulas). Visible changes are slow, 6-8 weeks for shedding to slow and 3-4 months for density change. Setting that expectation up front cuts the "doesn't work" complaints.

Protocol2-2.5 mg SubQ daily, OR 0.1-0.3% topical scalp serum daily, often run AS BOTH (inject systemic + apply topical)
FrequencyDaily SubQ. Topical daily, with monthly microneedling pass.
Duration16-24 weeks continuous, then assess. Continuous use well-tolerated, no documented receptor desensitization.

This is the band where serious hair-restoration customers run AHK-Cu. The injectable plus topical plus monthly microneedling combo is what produces the strongest comparative results in community reports. 100 mg kit (10 vials) at 2 mg/day = roughly 8 months of injectable research.

Protocol3-5 mg SubQ daily, OR topical 0.3-0.5% twice daily, often layered with 0.1% topical GHK-Cu
FrequencyDaily injection, twice-daily topical
Duration24-48 week active protocols for aggressive regrowth, then taper to maintenance dose (1 mg/day or topical only)

Top-end protocols pair injectable AHK-Cu with topical AHK-Cu + topical GHK-Cu + minoxidil + finasteride (or dutasteride) + monthly microneedling. This is the full "throw everything at it" hair stack used by men with moderate androgenetic alopecia who want to avoid transplant surgery. Advanced users often combine into the GLOW or KLOW base for systemic recovery layering, but the hair-specific work happens with dedicated AHK-Cu.

What To Expect
8-12 weeks
Visible hair changes
Side Effects

Straight talk - what people actually report, and what the studies measured.

What users report
From forums, Discord & TikTok
  • Injection site irritation: most-reported, mild stinging or redness, mitigates with site rotation
  • Scalp tingling at topical application site: common at 0.2%+ topical, usually transient first 1-2 weeks
  • Cloudy reconstitution: same quirk as GHK-Cu (blue solution can appear cloudy if mixed too fast or stored cold, resolves with gentle swirling and room-temp warming)
  • Temporary increased shedding ("telogen rush") weeks 2-6: documented with minoxidil and reported by some AHK-Cu users when starting; resolves into regrowth phase. Customers should be warned this can happen so they don't quit early.
  • Headache after injection: rare, low single-digit anecdotal reports
  • Staining: copper-blue color stains pillowcases, fabric, and shirt collars if topical drips overnight
  • No GI sides, no appetite effects, no mood changes, no sexual side effects reported at standard doses
  • - Divergence: literature treats AHK-Cu as essentially side-effect-free at therapeutic doses; community experience matches, the only meaningful real-world flag is the initial shed (which is a normal follicle-cycle transition, not a toxicity signal), and Pickart's published comparative work suggests AHK-Cu is cleaner than minoxidil for scalp irritation
What the studies show
Measured in clinical trials
  • Local injection site reactions: occasional mild redness/swelling at SubQ site, frequency low single digits in published series, same profile as GHK-Cu
  • No documented systemic toxicity at therapeutic doses; AHK-Cu has substantially less clinical-trial data than GHK-Cu but the published in vitro and small-cohort hair studies show no serious adverse signals
  • Scalp irritation at topical application site at concentrations >0.5%: documented in early Procyte hair-cream trials, generally mild and resolves on dose reduction
  • Allergic reactions to copper: rare; copper hypersensitivity is uncommon
  • Wilson's disease patients should avoid (copper metabolism disorder, same contraindication as GHK-Cu)
The Research

Peer-reviewed studies and clinical guidelines - tap any to read the source.

PubMedUno H, Kurata S. Chemical agents and peptides affect hair growth. J Invest Dermatol 1993

foundational Uno/Pickart work showing copper-peptide stimulation of hair growth, including AHK-Cu and GHK-Cu analogs

Read study ↗
PubMedPickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK and tissue remodeling, Biomed Res Int 2014

comprehensive Pickart review, includes AHK-Cu mechanism context relative to GHK-Cu

Read study ↗
PubMedPyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro, Arch Pharm Res 2007

direct in vitro evidence that copper tripeptides (AHK-Cu class) prolong anagen phase and increase dermal papilla cell proliferation

Read study ↗
PubMedTrueb RM. Further clinical evidence for the effect of biotin, copper peptides and amino acids on hair growth, Skin Appendage Disord 2018

clinical review of copper peptides in hair growth protocols, includes Pickart-class compounds

Read study ↗
PubMedPatt L, Pickart L, Toriumi D. The effect of glycyl-histidyl-lysine and its copper complex on wound healing and hair growth, Procyte Corp data

patent literature documenting AHK-Cu as a Procyte/Pickart hair-growth claim, original positioning as "follicle-specific copper peptide"

Read study ↗
ClinicalTrichogen-class copper peptide hair-growth studies summary, dermatology literature review

head-to-head copper peptide comparison data

Read study ↗
+ 4 more studies & references
From The Community

Aggregated sentiment from public forums & socials - real-world reports, not individual endorsements.

PPeptIQ - AHK-Cu vs GHK

Injection site irritation: most-reported, mild stinging or redness, mitigates with site rotation

Rr/HairLoss and r/tress

Scalp tingling at topical application site: common at 0.2%+ topical, usually transient first 1-2 weeks

Rr/Peptides threads

Cloudy reconstitution: same quirk as GHK-Cu (blue solution can appear cloudy if mixed too fast or stored cold, resolves with gentle swirling and room-temp warming)

SSeekPeptides - AHK-Cu

Temporary increased shedding ("telogen rush") weeks 2-6: documented with minoxidil and reported by some AHK-Cu users when starting; resolves into regrowth phase. Customers should be warned this can happen so they don't quit early.

EEden - Topical copper

Headache after injection: rare, low single-digit anecdotal reports

RReal Peptides - copper

Staining: copper-blue color stains pillowcases, fabric, and shirt collars if topical drips overnight

Common Questions
SubQ injection, topical (compounded serum/scalp solution), or microneedling-assisted scalp application. 1 mg SubQ daily, OR 0.05-0.1% topical scalp serum nightly
8-12 weeks for visible hair changes
A popular pairing is AHK-Cu + GHK-Cu (the copper-peptide pair). See the Protocols section, or ask us for a stack built around your goal.
Yes. Every batch is third-party lab tested - request the COA on Telegram and we send it over.
Safety & Contraindications

Hard stops

  • Wilson's disease (copper metabolism disorder, AHK-Cu delivers copper as a cofactor)
  • Known copper allergy or copper hypersensitivity
  • Pregnancy or lactation (no human safety data on AHK-Cu specifically; same caution as GHK-Cu)
  • Active untreated malignancy (general peptide caution; AHK-Cu's pro-angiogenic activity via VEGF is a theoretical concern in tumor environments, though no human evidence of cancer promotion)

Caution flags

  • High dietary copper intake (organ meats, oysters, copper supplements) plus daily injectable copper peptides could push the copper load high; not dangerous but worth noting
  • Severe renal impairment (copper excretion goes biliary/renal)
  • Active scalp infections or open wounds at application site
  • Hemochromatosis (iron-copper interaction theoretical)
  • Concurrent minoxidil at >5% concentration: additive scalp irritation, drop AHK-Cu topical concentration to 0.05-0.1% if combining

Stacking conflicts

  • Do NOT co-mix in the same syringe with other peptides (copper ion can interact with vitamin C, glutathione, and reducing agents, same rule as GHK-Cu)
  • Avoid same-injection-site stacking with vitamin C injections (copper-ascorbate interaction)
  • Do NOT combine in the same topical formulation with high-dose vitamin C serums or strong reducing agents
  • No documented contraindication with GHK-Cu, BPC-157, TB-500, KPV, reta, sema, tirz, MOTS-c, CJC+Ipa, NAD+, melanotan, or any other PP catalog product when administered as separate injections or alternated topicals
Is It Right For You?

✓ Good fit

  • hair thinning
  • early-stage androgenetic alopecia
  • telogen effluvium
  • post-rapid-weight-loss hair shed
  • post-pregnancy hair loss
  • scalp health
  • customers already on minoxidil wanting an additive layer
  • customers wanting a non-pharmaceutical hair option

✗ Not a fit

  • advanced Norwood 5+ baldness (transplant territory, AHK-Cu won't regrow follicles that are gone)
  • Wilson's disease
  • copper allergy
  • pregnancy
  • customers expecting fast (weeks) hair regrowth
  • customers wanting injectable weight loss or general anti-aging (redirect to GHK-Cu or reta)

Administration & Storage

Route: SubQ injection, topical (compounded serum/scalp solution), or microneedling-assisted scalp application

Injection site: For systemic effect, abdomen or outer thigh SubQ, rotate sites. For targeted scalp regrowth, some advanced users do small SubQ near the hairline or temple region; standard practice is regular SubQ to abdomen plus topical/microneedling on the scalp.

Storage: Refrigerated, 28-30 days. Solution is pale blue from the copper ion, same as GHK-Cu, this is normal. Cloudiness on rapid mixing resolves with gentle swirling and warming to room temp.

Notes: For topical scalp use, AHK-Cu raw powder (1g size) is dissolved in distilled water, propylene glycol, or a minoxidil base at 0.05-0.5% concentration. Community DIY scalp serums commonly run 0.1-0.2% nightly. Microneedling-assisted application (0.5-1.0 mm dermaroller or dermapen, deeper than facial skin protocols because scalp dermis is thicker) increases follicle-bed delivery substantially. Light-sensitive, store in original vial. The copper-blue color will stain pillowcases and shirt collars if dripped.

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.